These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 596356)

  • 1. The effect of portacaval shunting in the alcoholic cirrhotic on serum cholesterol concentration. A retrospective study.
    Kuo JY; Dreiling DA
    Am J Gastroenterol; 1977; 68(3):270-2. PubMed ID: 596356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differential alcohol elimination in portal hypertension and after portacaval shunt].
    Mittmeyer HJ; Steegmüller KW
    Beitr Gerichtl Med; 1981; 39():295-301. PubMed ID: 7305858
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is portacaval anastomosis still valid treatment for portal hypertension in alcoholic cirrhotic patients?].
    Paineau J; Lehur PA; Leborgne J; Lenne Y; Perrin D; Visset J
    J Chir (Paris); 1984; 121(8-9):471-6. PubMed ID: 6334096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate and long-term portal hemodynamic consequences of small-diameter H-graft portacaval shunt.
    Zervos EE; Goode SE; Rosemurgy AS
    J Surg Res; 1998 Jan; 74(1):71-5. PubMed ID: 9536977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portacaval shunt as emergency procedure in unselected patients with alcoholic cirrhosis.
    Orloff MJ; Charters AC; Chandler JG; Condon JK; Grambort DE; Modafferi TR; Levin SE; Brown NB; Sviokla SC; Knox DG
    Surg Gynecol Obstet; 1975 Jul; 141(1):59-68. PubMed ID: 1154215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Portacaval shunt with H-grafts of small diameter in treating cirrhotic patients with portal hypertension].
    Leng X; Zhu J; Du R
    Zhonghua Wai Ke Za Zhi; 1998 Jun; 36(6):330-2. PubMed ID: 11825402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
    Shurberg JL; Resnick RH; Koff RS; Ros E; Baum RA; Pallotta JA
    Gastroenterology; 1977 Feb; 72(2):301-4. PubMed ID: 830579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts].
    Feng H; Zhang Z; Leng X; Li S; Zhu J; Du R
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):222-4. PubMed ID: 11829825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver.
    Orloff MJ; Orloff MS; Orloff SL; Rambotti M; Girard B
    J Am Coll Surg; 1995 Mar; 180(3):257-72. PubMed ID: 7874335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing pattern of portasystemic shunt surgery.
    van der Vliet JA; de Visser E; Buskens FG
    Eur J Surg; 1995 Dec; 161(12):877-80. PubMed ID: 8775628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The levels of renin activity, angiotensin converting enzyme and angiotensin II in cirrhotic patients with ascites undergoing portacaval shunt].
    Zhang Z; Feng H; Leng X; Ma F; Wang B; Du R
    Zhonghua Wai Ke Za Zhi; 1999 Jun; 37(6):366-8. PubMed ID: 11829864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate changes in blood flow and oxygen metabolism of the cirrhotic liver following portacaval shunt operations.
    Delin NA; Ekeström S; Lindahl J; Nylander G; Sundblad R
    Surg Gynecol Obstet; 1977 Apr; 144(4):499-503. PubMed ID: 847602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy of splenectomy and portacaval tissue anastomoses in patients with liver cirrhosis].
    Sokolova GM
    Vrach Delo; 1967 Apr; 4():24-8. PubMed ID: 5612192
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of the secretion of pepsinogen I in cirrhotic humans with and without portacaval shunt.
    Albillos A; Abreu L; Alvarez-Mon M; Gea F; Gonzalo MA; Rossi I; Garrido A; Barrios C; Escartín P
    Am J Gastroenterol; 1988 Jan; 83(1):37-41. PubMed ID: 3337058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Variations in the numbers of thrombocytes and leukocytes in cirrhotic patients with portacaval shunt].
    Karády G; Karácsonyi S; Stekker K; Szloboda J; Szécsény A
    Acta Chir Acad Sci Hung; 1969; 10(3):325-9. PubMed ID: 5310101
    [No Abstract]   [Full Text] [Related]  

  • 17. [Perioperative plasma amino acid spectrum analysis in portal hypertensive cirrhotic patients undergoing portacaval H-graft shunt].
    Zhu J; Liu F; Leng X
    Zhonghua Wai Ke Za Zhi; 1997 May; 35(5):299-301. PubMed ID: 10374569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Resuscitation and postoperative treatment of cirrhotic patients operated on for poral hypertension].
    Gasparetto A; Gritti G; Carlon G; Manzin E; Brinis A
    Acta Anaesthesiol; 1971; 22(2):173-87. PubMed ID: 5171558
    [No Abstract]   [Full Text] [Related]  

  • 19. The predictive value of serum laminin for the risk of variceal bleeding related to portal pressure levels.
    Kondo M; Miszputen SJ; Leite-mor MM; Parise ER
    Hepatogastroenterology; 1995; 42(5):542-5. PubMed ID: 8751212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilharzial portal fibrosis: an important cause of portal hypertension.
    Carruthers RH; Sinha P
    Ann R Coll Surg Engl; 1978 Jan; 60(1):49-52. PubMed ID: 626472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.